Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 192282011000036110 | Asasantin SR (aspirin 25 mg + dipyridamole 200 mg) modified release capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 192284011000036118 | Asasantin SR modified release capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Asasantin SR modified release capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Asasantin SR modified release capsule | Is a | Asasantin SR | true | Inferred relationship | Some | ||
| Asasantin SR modified release capsule | Is a | dipyridamole 200 mg + aspirin 25 mg modified release capsule | true | Inferred relationship | Some | ||
| Asasantin SR modified release capsule | has intended active ingredient | aspirin | true | Inferred relationship | Some | 668070376 | |
| Asasantin SR modified release capsule | has intended active ingredient | dipyridamole | true | Inferred relationship | Some | 1802674610 | |
| Asasantin SR modified release capsule | has Australian BoSS | dipyridamole | true | Inferred relationship | Some | 1802674610 | |
| Asasantin SR modified release capsule | has manufactured dose form | modified release capsule | true | Inferred relationship | Some | ||
| Asasantin SR modified release capsule | has unit of use | capsule | true | Inferred relationship | Some | 1802674611 | |
| Asasantin SR modified release capsule | has Australian BoSS | aspirin | true | Inferred relationship | Some | 668070376 |
Reference Sets
Trade product unit of use reference set
FHIR